9:35am ET
Health and Healthcare
Biotech Short Sellers Run for Cover
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Companies
Celgene
$108.24
▲ $0.00 (+0.00%) today
Markets closed · 7:20am ET
CELG Coverage
Page 11
8:35am ET
Health and Healthcare
Jefferies Has 5 Top Biotech Stocks to Buy for 2017
Needless to say, the past two years have been rough on biotech. The question for investors is which of the stocks hold the best potential in 2017.
10:10am ET
Health and Healthcare
Biotech Short Interest Sinks
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
8:25am ET
Health and Healthcare
RBC Likes Large Cap Biotech Leaders for 2017
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More
Tthe top analyst upgrades, downgrades and initiations seen on Tuesday morning include Amgen, American Express, American Water Works, Celgene and Square.
9:10am ET
Health and Healthcare
Biotech Short Interest Remains Mixed
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
7:35am ET
Health and Healthcare
Short Sellers Grow More Aggressive on Major Biotechs
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
7:20am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for…
7:15am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
10:35am ET
Health and Healthcare
Top Health Care Earnings Coming Next Week
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
9:55am ET
Health and Healthcare
Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
9:55am ET
Health and Healthcare
Top Biotech Plays Highlight Jefferies Growth Stocks to Buy
Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good sense now and have outstanding upside potential.
7:10am ET
Health and Healthcare
Short Sellers Have Mixed Views on Major Biotechs
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
9:50am ET
Health and Healthcare
Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among the stocks to buy.